Literature DB >> 8960568

A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia.

R T Brown1, M B Sawyer, G Antoniou, I Toogood, M Rice, N Thompson, A Madan-Swain.   

Abstract

This prospective study compared the intellectual and academic functioning of two groups of children treated for cancer over the 3 years after their diagnosis. One group consisted of children who received central nervous system (CNS) prophylactic chemotherapy, and the other group consisted of children with cancer who did not receive CNS chemotherapy. The results suggest that the children who received CNS chemotherapy experienced more adverse effects from their treatment in the area of academic functioning than the children who did not receive CNS chemotherapy. Although there were no differences in the academic functioning of the two groups of children immediately after their diagnosis, 3 years postdiagnosis, the CNS-treated children scored more poorly on academic tests of reading, spelling, and arithmetic than the non-CNS-treated children. The results suggest that CNS chemotherapy prophylaxis may impede academic achievement.

Entities:  

Mesh:

Year:  1996        PMID: 8960568     DOI: 10.1097/00004703-199612000-00004

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  12 in total

1.  Mathematics intervention for prevention of neurocognitive deficits in childhood leukemia.

Authors:  Ida M Moore; Marilyn J Hockenberry; Cynthia Anhalt; Kathy McCarthy; Kevin R Krull
Journal:  Pediatr Blood Cancer       Date:  2011-09-21       Impact factor: 3.167

2.  Neurodevelopmental functioning in very young children undergoing treatment for non-CNS cancers.

Authors:  Marc H Bornstein; Sara Scrimin; Diane L Putnick; Fabia Capello; O Maurice Haynes; Simona de Falco; Modesto Carli; Marta Pillon
Journal:  J Pediatr Psychol       Date:  2012-02-02

Review 3.  Topics in pediatric leukemia--acute lymphoblastic leukemia and late effects in long-term survivors.

Authors:  Jacqueline Casillas; Kathleen M Sakamoto
Journal:  MedGenMed       Date:  2005-03-07

4.  Reduced frontal white matter volume in long-term childhood leukemia survivors: a voxel-based morphometry study.

Authors:  M E Carey; M W Haut; S L Reminger; J J Hutter; R Theilmann; K L Kaemingk
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

5.  The Association Between Motor Skills and Academic Achievement Among Pediatric Survivors of Acute Lymphoblastic Leukemia.

Authors:  Lyn M Balsamo; Kyaw J Sint; Joseph P Neglia; Pim Brouwers; Nina S Kadan-Lottick
Journal:  J Pediatr Psychol       Date:  2015-10-29

6.  F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.

Authors:  Marilyn J Hockenberry; Olga A Taylor; Patricia M Gundy; Adam K Ross; Alice Pasvogel; David Montgomery; Phillip Ribbeck; Kathy McCarthy; Ida Moore
Journal:  Biol Res Nurs       Date:  2013-08-15       Impact factor: 2.522

7.  Neurocognitive Predictors of Academic Outcomes Among Childhood Leukemia Survivors.

Authors:  Ida M Ki Moore; Philip J Lupo; Kathleen Insel; Lynnette L Harris; Alice Pasvogel; Kari M Koerner; Kristin B Adkins; Olga A Taylor; Marilyn J Hockenberry
Journal:  Cancer Nurs       Date:  2016 Jul-Aug       Impact factor: 2.592

8.  Caregiver Sexual and HPV Communication Among Female Survivors of Childhood Cancer.

Authors:  Courtney Peasant; Rebecca H Foster; Kathryn M Russell; Brianne E Favaro; James L Klosky
Journal:  J Pediatr Oncol Nurs       Date:  2015-12-14       Impact factor: 1.636

9.  Comparison of intelligence quotient in children surviving leukemia who received different prophylactic central nervous system treatments.

Authors:  Reisi Nahid; Khalilian Leila
Journal:  Adv Biomed Res       Date:  2012-10-31

10.  Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only.

Authors:  G Elisabeth Lofstad; Trude Reinfjell; Knut Hestad; Trond H Diseth
Journal:  Acta Paediatr       Date:  2008-09-30       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.